首页> 外文期刊>Medicinal chemistry >Synthesis, Crystal Structure, Anti-inflammatory and Anti-hyperglycemic Activities of Novel 3,4-Disubstituted 1,2,4-Triazol-5(4H)-one Derivatives
【24h】

Synthesis, Crystal Structure, Anti-inflammatory and Anti-hyperglycemic Activities of Novel 3,4-Disubstituted 1,2,4-Triazol-5(4H)-one Derivatives

机译:新型3,4-二取代的1,2,4-三唑-5(4H)-one衍生物的合成,晶体结构,抗炎和抗高血糖活性

获取原文
获取原文并翻译 | 示例
           

摘要

A new series of 3,4-disubstituted 1,2,4-triazol-5(4H)-one 5a-r, bearing various methoxyphenyl, fluorophenyl, tolyl and phenyl groups, was synthesized by the dehydrocyclization of hydrazinecarboxamides 4a-r by refluxing in a 2 N sodium hydroxide solution. Hydrazinecarboxamides 4a-r was synthesized via the condensation of the corresponding aralkanoic acid hydrazides, 3a-g, with fluoro-, tolyl- and methoxyphenylisocyanates. The newly synthesized compounds (5a-r) were characterized by IR, H-1 NMR and C-13 NMR analyses. The structure of one compound 5a was determined by single crystal X-ray diffraction analysis. All of the synthesized compounds were screened for their anti-inflammatory and anti-diabetic (alpha-glucosidase and alpha-amylase inhibition) activity to identify new drugs that might be useful in preventing damage related to diabetes and inflammation. Compounds 5j, 5k and 5m decrease the expression of type II collagen in a dose dependent manner; similarly 5l decrease the COX-2 expression of rabbit articular chondrocytes in a dose dependent manner possessing potent anti-inflammatory potential while some of derivatives including 5c, 5e, 5g and 5h cause inflammation. Meanwhile, excellent alpha-glucosidase and moderate alpha-amylase inhibitory profiles against carbohydrate modulating enzymes were demonstrated by compounds 5b, 5f, 5k and 5q compared to the reference standard acarbose, and compounds 5g, 5h, 5i, 5j, 5l and 5o exhibited moderate to low enzyme inhibition potential among the series.
机译:通过肼甲酰胺4a-r的脱氢环化反应,合成了一系列新的3,4-二取代的1,2,4-三唑-5(4H)-一个5a-r,带有多个甲氧基苯基,氟苯基,甲苯基和苯基。在2 N氢氧化钠溶液中。通过使相应的链烷酸酰肼3a-g与氟,甲苯基和甲氧基苯基异氰酸酯缩合来合成肼甲酰胺4a-r。通过IR,H-1 NMR和C-13 NMR分析表征了新合成的化合物(5a-r)。通过单晶X射线衍射分析确定一种化合物5a的结构。筛选所有合成的化合物的抗炎和抗糖尿病(α-葡萄糖苷酶和α-淀粉酶抑制作用)活性,以鉴定可用于预防与糖尿病和炎症相关的损害的新药。化合物5j,5k和5m以剂量依赖性方式降低II型胶原蛋白的表达。类似地,5l以剂量依赖性的方式降低兔关节软骨细胞的COX-2表达,具有强大的抗炎潜能,而包括5c,5e,5g和5h在内的某些衍生物会引起炎症。同时,与参考标准阿卡波糖相比,化合物5b,5f,5k和5q表现出了优异的α-葡萄糖苷酶和中度α-淀粉酶对碳水化合物调节酶的抑制特性,化合物5g,5h,5i,5j,5l和5o表现出中度抑制作用在系列中具有较低的酶抑制潜力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号